These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 25811447

  • 1. Hemorrhagic risk due to platelet dysfunction in myelodysplastic patients, correlations with anemia severity and iron overload.
    Popov VM, Vladareanu AM, Bumbea H, Kovacs E, Savopol T, Iordache MM, Moisescu MG.
    Blood Coagul Fibrinolysis; 2015 Oct; 26(7):743-9. PubMed ID: 25811447
    [Abstract] [Full Text] [Related]

  • 2. Assessment of changes in membrane properties of platelets from patients with chronic myeloid leukaemia in different stages of the disease.
    Popov VM, Vladareanu AM, Bumbea H, Kovacs E, Moisescu MG, Onisai M, Iordache MM, Savopol T.
    Blood Coagul Fibrinolysis; 2014 Mar; 25(2):142-50. PubMed ID: 24346354
    [Abstract] [Full Text] [Related]

  • 3. Defective platelet aggregation in myelodysplastic syndromes.
    Girtovitis FI, Ntaios G, Papadopoulos A, Ioannidis G, Makris PE.
    Acta Haematol; 2007 Mar; 118(2):117-22. PubMed ID: 17726306
    [Abstract] [Full Text] [Related]

  • 4. Platelet function alterations and their relation to P-selectin (CD62P) expression in children with iron deficiency anemia.
    Yıldırım ZK, Orhan MF, Büyükavcı M.
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):98-101. PubMed ID: 21245745
    [Abstract] [Full Text] [Related]

  • 5. Alterations of platelet functions in children and adolescents with iron-deficiency anemia and response to therapy.
    Mokhtar GM, Ibrahim WE, Kassim NA, Ragab IA, Saad AA, Abdel Raheem HG.
    Platelets; 2015 Mar; 26(5):448-52. PubMed ID: 25026531
    [Abstract] [Full Text] [Related]

  • 6. Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.
    Zheng QQ, Zhao YS, Guo J, Zhao SD, Song LX, Fei CM, Zhang Z, Li X, Chang CK.
    Leuk Res; 2017 Jul; 58():55-62. PubMed ID: 28460338
    [Abstract] [Full Text] [Related]

  • 7. Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes.
    Angelucci E, Cianciulli P, Finelli C, Mecucci C, Voso MT, Tura S.
    Leuk Res; 2017 Nov; 62():108-115. PubMed ID: 29054020
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry.
    Albanyan A, Al-Musa A, AlNounou R, Al Zahrani H, Nasr R, AlJefri A, Saleh M, Malik A, Masmali H, Owaidah T.
    Int J Lab Hematol; 2015 Aug; 37(4):503-8. PubMed ID: 25537026
    [Abstract] [Full Text] [Related]

  • 9. Platelet dysfunction in acute leukemias and myelodysplastic syndromes.
    Vlădăreanu AM, Vasilache V, Bumbea H, Onisâi M.
    Rom J Intern Med; 2011 Aug; 49(1):93-6. PubMed ID: 22026258
    [Abstract] [Full Text] [Related]

  • 10. Platelet function and its clinical significance in the myelodysplastic syndromes.
    Zeidman A, Sokolover N, Fradin Z, Cohen A, Redlich O, Mittelman M.
    Hematol J; 2004 Aug; 5(3):234-8. PubMed ID: 15167910
    [Abstract] [Full Text] [Related]

  • 11. Abnormal platelet phenotypes in patients with myelodysplastic syndromes.
    Liu J, Niu H, Yue L, Lv Q, Yang L, Liu C, Jiang H, Xing L, Shao Z, Wang H.
    Int J Lab Hematol; 2020 Aug; 42(4):371-379. PubMed ID: 32202052
    [Abstract] [Full Text] [Related]

  • 12. The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
    Gu S, Song X, Zhao Y, Guo J, Fei C, Xu F, Wu L, Zhang X, Zhao J, Chang C, Li X.
    Hematology; 2013 Sep; 18(5):286-94. PubMed ID: 23540794
    [Abstract] [Full Text] [Related]

  • 13. Platelet function in the myelodysplastic syndromes.
    Mittelman M, Zeidman A.
    Int J Hematol; 2000 Feb; 71(2):95-8. PubMed ID: 10745619
    [Abstract] [Full Text] [Related]

  • 14. Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae.
    Kim CH, Leitch HA.
    Crit Rev Oncol Hematol; 2021 Jul; 163():103367. PubMed ID: 34058341
    [Abstract] [Full Text] [Related]

  • 15. Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox.
    Kikuchi S, Kobune M, Iyama S, Sato T, Murase K, Kawano Y, Takada K, Ono K, Kaneko Y, Miyanishi K, Sato Y, Hayashi T, Takimoto R, Kato J.
    Free Radic Biol Med; 2012 Aug 15; 53(4):643-8. PubMed ID: 22705364
    [Abstract] [Full Text] [Related]

  • 16. Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes.
    Hlaváčková A, Štikarová J, Pimková K, Chrastinová L, Májek P, Kotlín R, Čermák J, Suttnar J, Dyr JE.
    Free Radic Biol Med; 2017 Jul 15; 108():1-7. PubMed ID: 28300669
    [Abstract] [Full Text] [Related]

  • 17. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
    Martín M, de Paz R, Jiménez-Yuste V, Fernández Bello I, García Arias Salgado E, Alvarez MT, Butta NV.
    Thromb Haemost; 2013 May 15; 109(5):909-19. PubMed ID: 23407717
    [Abstract] [Full Text] [Related]

  • 18. Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome.
    Cuijpers ML, Raymakers RA, Mackenzie MA, de Witte TJ, Swinkels DW.
    Br J Haematol; 2010 May 15; 149(3):322-33. PubMed ID: 20067561
    [Abstract] [Full Text] [Related]

  • 19. Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes.
    Hua Y, Wang C, Jiang H, Wang Y, Liu C, Li L, Liu H, Shao Z, Fu R.
    Int J Hematol; 2017 Aug 15; 106(2):248-257. PubMed ID: 28405919
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.